Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer.

Speyer, J L

Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer. [electronic resource] - The New England journal of medicine Sep 1988 - 745-52 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0028-4793

10.1056/NEJM198809223191203 doi


Adult
Aged
Breast Neoplasms--drug therapy
Cyclophosphamide--administration & dosage
Doxorubicin--administration & dosage
Drug Tolerance
Female
Fluorouracil--administration & dosage
Heart--diagnostic imaging
Heart Failure--chemically induced
Humans
Middle Aged
Myocardium--pathology
Piperazines--therapeutic use
Radionuclide Imaging
Random Allocation
Razoxane--administration & dosage
Stroke Volume